Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT01639508
Brief Title: Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

First Submitted : July 10, 2012
First Submitted that Met QC Criteria : July 11, 2012
First Posted : July 12, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : October 11, 2021
Last Update Posted : October 12, 2021